Open Nav

Please submit your session questions in advance at

Stefano Gulla



Stefano Gullà is the Co-founder and CEO of Abcuro Inc., a biotech startup focused on developing first-in-class therapeutic antibodies for immuno-oncology and autoimmunity indications. Prior to his role at Abcuro, Stefano led several drug discovery programs from target validation to clinical stage as a Program Leader at Pfizer and later at Agenus managing a portfolio of early stage assets. He brings to Abcuro a track record of pharma industry leadership, program management and drug discovery experience. Stefano is trained in biophysics and protein engineering at Northeastern University and MIT.

This speaker's sessions: